{"id":165514,"date":"2018-05-30T01:52:10","date_gmt":"2018-05-30T05:52:10","guid":{"rendered":"https:\/\/canadianinquirer.net\/v1\/?p=165514"},"modified":"2018-05-30T01:52:10","modified_gmt":"2018-05-30T05:52:10","slug":"fda-orders-review-of-energy-drinks","status":"publish","type":"post","link":"https:\/\/canadianinquirer.net\/v1\/2018\/05\/30\/fda-orders-review-of-energy-drinks\/","title":{"rendered":"FDA orders review of energy drinks"},"content":{"rendered":"<figure id=\"attachment_96440\" aria-describedby=\"caption-attachment-96440\" style=\"width: 599px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2017\/04\/537497_456436451079081_563310028_n.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-96440\" src=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2017\/04\/537497_456436451079081_563310028_n.jpg\" alt=\"In a statement, FDA Director General Nela Puno said Ravena's case would a good opportunity to re-examine the content and labelling of energy drinks. (Photo: Food and Drug Administration Philippines\/ Facebook)\" width=\"599\" height=\"599\" srcset=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2017\/04\/537497_456436451079081_563310028_n.jpg 599w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2017\/04\/537497_456436451079081_563310028_n-150x150.jpg 150w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2017\/04\/537497_456436451079081_563310028_n-300x300.jpg 300w\" sizes=\"auto, (max-width: 599px) 100vw, 599px\" \/><\/a><figcaption id=\"caption-attachment-96440\" class=\"wp-caption-text\">In a statement, FDA Director General Nela Puno said Ravena&#8217;s case would a good opportunity to re-examine the content and labelling of energy drinks. (<a href=\"https:\/\/www.facebook.com\/FDAPhilippines\/photos\/a.441718339217559.102642.441718202550906\/456436451079081\/?type=1&amp;amp;theater\">Photo: Food and Drug Administration Philippines\/ Facebook<\/a>)<\/figcaption><\/figure>\n<p><strong>MANILA<\/strong>\u00a0&#8212; Amid the controversy surrounding Philippine basketball player Kiefer Ravena, the Food and Drug Administration (FDA) on Tuesday called for a review of available workout and energy drinks in the market.<\/p>\n<p>In a statement, FDA Director General Nela Puno said Ravena&#8217;s case would a good opportunity to re-examine the content and labelling of energy drinks.<\/p>\n<p>&#8220;I will immediately direct a thorough review of these products to protect the health and fitness conscious public,\u201d Puno said.<\/p>\n<p>Under the FDA Act of 2009, the agency is mandated to ensure the safety, efficacy, purity, and quality of food products, medicines, cosmetics, and medical devices.<\/p>\n<p>On Monday, the Samahang Basketbol ng Pilipinas (SBP) announced that Ravena had been suspended for 18 months by the International Basketball Federation (FIBA).<\/p>\n<p>Ravena was tested positive for three banned substances believed from a pre-workout drink he took called &#8220;DUST\u201d, back in February while he was playing for the Gilas Pilipinas national men\u2019s basketball team.<\/p>\n<p>Meanwhile, in an interview, health reform advocate Dr. Anthony Leachon expressed support to FDA\u2019s move.<\/p>\n<p>Leachon said that having a set of guidelines, especially proper labelling for energy drinks, is needed.<\/p>\n<p>He said unregulated energy drinks may cause cardiac arrhythmia, high blood pressure, lack of sleep, among others.<\/p>\n<p>\u201cFDA guidelines are badly needed at this point in time&#8230;at the moment, it\u2019s over-the-counter, and people don\u2019t know what they\u2019re taking,\u201d he said.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MANILA\u00a0&#8212; Amid the controversy surrounding Philippine basketball player Kiefer Ravena, the Food and Drug Administration (FDA) on Tuesday called for &hellip;<\/p>\n","protected":false},"author":33,"featured_media":96440,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[51450,4712,7866],"class_list":["post-165514","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-energy-drinks","tag-fda","tag-kiefer-ravena","mauthors-leilani-junio","mauthors-philippine-news-agency"],"_links":{"self":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/165514","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/comments?post=165514"}],"version-history":[{"count":0,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/165514\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media\/96440"}],"wp:attachment":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media?parent=165514"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/categories?post=165514"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/tags?post=165514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}